With the growing number of new radiopharmaceuticals, the SNMMI saw an opportunity to convene and develop resources to ensure patients receive high quality and safe care. The SNMMI Committee on Quality and Patient Safety is co-chaired by Dr. Munir Ghesani and Dr. Helen Nadel. Our mission is to, "Ensure that SNMMI members provide high quality care to their patients during examination and in treatments they perform". The committee identified several goals, including:
• Draft a paper outlining ‘best practices’ for the administration of radiopharmaceutical therapies
• Work with radiopharmaceutical developers and distributors to ensure the handling and labeling of all radiopharmaceuticals from manufacture to administration to the patient
• Create a webpage to house all safety-related tools on the SNMMI website
With this tool, specify the nuclear medicine procedure, the injected activity, and the patient model (gender, age) to calculate the effective dose for this procedure.
With this tool, specify the nuclear medicine procedure and the pediatric patient’s weight to find the recommended administered activity for the patient.
The procedure standards help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of procedure standards will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some standards were formally adopted by SNMMI in collaboration with other professional organizations.
Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process.
The SNMMI credentialing statements were developed in an effort to provide guidance for practitioners and institutions regarding the training required to perform, supervise, interpret and report nuclear medicine procedures, as well as related correlative imaging studies.
Continuing quality assurance is an integral part of the present-day practice of medicine. The Intersocietal Accreditation Commission (IAC), Nuclear/PET | ICANL (formerly the ICANL) offers accreditation as an increasingly renowned method for Nuclear Medicine, Nuclear Cardiology and PET facilities to evaluate and demonstrate the level of patient care they provide.
Image Gently and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) created the “Go With the Guidelines” awareness campaign to encourage community hospitals, academic hospitals and clinics to observe standardized guidelines on radiopharmaceutical dose for pediatric patients.
Image Wisely was created with the objective of lowering the amount of radiation used in medically necessary imaging studies and eliminating unnecessary procedures.
The U.S. Nuclear Regulatory Commission (NRC) was created as an independent agency by Congress in 1974 to ensure the safe use of radioactive materials for beneficial civilian purposes while protecting people and the environment. The NRC regulates commercial nuclear power plants and other uses of nuclear materials, such as in nuclear medicine, through licensing, inspection and enforcement of its requirements.
A variety of webinars relevant to SNMMI, dealing with topics ranging from new guidelines to how to best comply with the Physician Quality Reporting System.